Navigation Links
AMDL Announces First Quarter 2008 Results Posting Sales of $3.58 Million
Date:5/15/2008

of AMDL, stated that, "The continued improvements in AMDL's China operations, combined with other recently announced business opportunities create a financial platform for us to improve our sales and earnings profile during the remainder of FY2008 and beyond. This gives us greater confidence in AMDL's continued positive financial performance over the next year." AMDL's 2007 results as well as business improvement and opportunities referenced above include:

-- FY2007 Sales of $15 Million and Gross Profits of $8.1 million;

-- In-licensed MyGene's Human Papilloma Virus (HPV) Diagnostic Test;

-- Signed LOI for the purchase of a China based pharmaceutical

distribution company with $28.55 million in revenue, approximately 10%

NOI and 20-30% growth rate;

-- Signed MOU with Hau Du Beauty Co., Ltd for its 200 stores to

distribute Jade's Goodnak Product Line;

-- AMDL launched a new updated website at http://www.amdl.com.

About AMDL: More information about AMDL and its products can be obtained at http://www.amdl.com. AMDL, together with Jade, engages in the development, manufacture and marketing of proprietary pharmaceutical and diagnostic products.

About Jade Pharmaceuticals Inc.: JPI has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its Jade subsidiaries, currently holds licenses for 133 products that are manufactured as large volume injection fluids, tablets and other related products. It currently manufactures over 20 key generic, over-the-counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

Forward-looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are s
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioMS Medical announces first quarter 2008 results
2. Bioheart, Inc. Announces Financial Results for First Quarter 2008
3. BioElectronics Announces Conference Call to Update Investors on Growth Initiatives
4. KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
5. Vermillion Announces First Quarter 2008 Financial Results and Business Progress
6. Surface Logix Announces Executive Management Changes
7. Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities
8. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
9. China Biologic Products Announces First Quarter 2008 Results Conference Call
10. 3SBio Inc. Announces First Quarter 2008 Results
11. LifeStem International, Inc. Announces Increased Revenues, Decreased Operating Expenses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2010)... Stock Exchange Symbol: MS , ... , , ... ... EDMONTON , March 16 ... ...
(Date:3/16/2010)... PharmAthene, Inc. (Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results ... ... , ... ... ...
(Date:3/16/2010)... March 16 The Gynecologic Cancer Foundation (GCF) and the Claudia ... as the first recipient of the $50,000 GCF/Claudia Cohen Prize for Outstanding ... (SGO) 41st Annual Meeting on Women,s Cancer, meeting in San Francisco ... ... ...
(Date:3/16/2010)... (LSE: SHP,NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice ... New Drug Application ("ANDA") for a generic version of Shire,s 1,mg, 2mg, ... ... ... , ...
Breaking Biology Technology:BioMS Medical Announces 2009 Year End Results 2BioMS Medical Announces 2009 Year End Results 3BioMS Medical Announces 2009 Year End Results 4BioMS Medical Announces 2009 Year End Results 5BioMS Medical Announces 2009 Year End Results 6BioMS Medical Announces 2009 Year End Results 7BioMS Medical Announces 2009 Year End Results 8BioMS Medical Announces 2009 Year End Results 9BioMS Medical Announces 2009 Year End Results 10PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 2PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 2Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 4Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 5Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 2Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 3Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 4
... Samter Journalism Awards ... Entry Deadline: October 31, 2007, MILWAUKEE, Sept. ... the largest professional medical specialty,organization in the United States representing ... special interest in the research and treatment of allergic disease,is ...
... 28 /PRNewswire-FirstCall/ - Neptune Technologies &,Bioressources Inc. (NASDAQ.NEPT ... for the fiscal year ended May 31, 2007. ... and operational,profitability while continuing its business development strategy ... in,sustainable sales growth. Financial Results and Highlights:, ...
... day, someone dies,of melanoma in the United States, making this ... worldwide. Since 1975, the incidence rate,of new melanomas has more ... and both sexes. Currently, there are more new,cases of melanoma ... early there is an excellent chance of recovery. Katie ...
Other Biology Technology:AAAAI: Call for Entries: Have You Written a Story on Allergic Disease? Win $1000 2Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results 2Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results 3Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers 2
(Date:3/18/2010)... can live for twenty years, fertilizing millions of eggs ... activity. , Danish researchers who have studied ants ... 1992 discovered that in both ant and bee species ... fluid favors the survival of its own sperm over ... stored, leafcutter ant queens neutralize male-male sperm competition with ...
(Date:3/18/2010)... available in Spanish . , Feeding ... as part of their regular diet makes them ... a study by Agricultural Research Service (ARS) scientists ... and overall behavioral activity among young female pigs ... acquired through diet, is the precursor for the ...
(Date:3/18/2010)... Biotech, Inc., ( www.genwaybio.com ) the US-based diagnostic company ... is expanding this cancer testing program internationally. An ... YouTM Cancer Assessment in Greece starting in April. ... as well. GenWay currently offers this test in ... Sergey Sikora, Vice President of Business Development, said, "The ...
Breaking Biology News(10 mins):Females shut down male-male sperm competition in leafcutter ants 2Tryptophan-enriched diet reduces pig aggression 2Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 1Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 2Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 1Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 1Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 3
... mouse repeatedly experiences defeat by a dominant animal disappears ... in a brain circuit for social learning, scientists funded ... of Mental Health (NIMH) have discovered. Mice engineered ... in spite of repeated social defeat. Their unaltered peers ...
... M. Erickson sliced up some ancient dinosaur bones ... of scientists identify a new genus and species. ... the FSU researcher determined that the two remarkably ... Tyrannosaurus rex. , Make that distant cousins –?the ...
... Services (HHS) today announced the creation of two new, ... causes of common diseases such as asthma, arthritis and ... the National Institutes of Health (NIH) for a multi-institute ... common illnesses. The other initiative launches a public-private partnership ...
Other Biology News:Mice lacking social memory molecule take bullying in stride 2Mice lacking social memory molecule take bullying in stride 3FSU biologist says new dinosaur is oldest cousin of Tyrannosaurus rex 2FSU biologist says new dinosaur is oldest cousin of Tyrannosaurus rex 3Two NIH initiatives launch intensive efforts to find roots of common diseases 2Two NIH initiatives launch intensive efforts to find roots of common diseases 3Two NIH initiatives launch intensive efforts to find roots of common diseases 4Two NIH initiatives launch intensive efforts to find roots of common diseases 5Two NIH initiatives launch intensive efforts to find roots of common diseases 6Two NIH initiatives launch intensive efforts to find roots of common diseases 7Two NIH initiatives launch intensive efforts to find roots of common diseases 8
...
... agent. Inhibits several important steps of angiogenesis including ... cells. Also reduces intracellular reactive oxygen species (ROS) ... endothelial cells. Formula: ... MolWeight: 360.31484 ...
... Zero Background Cloning Kit includes the pZErO-1 ... E. coli. The pZErO-1 vector utilizes positive ... size of the Zeocin resistance gene reduces ... and transformation efficiencies. The kit contains all ...
NATIVE, ENZYME PORCINE TRYPSIN...
Biology Products: